ORTEXORTEX News
Tracking ECL? Get live short interest, options flow, and signals on ORTEX.Sign up free →
EC
Earnings PreviewECL

Ecolab Shorts Retreat as Peers Face Heavier Selling

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 24 Oct 2026, 04:00

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Among the specialty chemicals names closest to ECL, short positioning varies sharply. SHW and RPM have seen their shares fall 2.5% and 2.9% respectively in a single session, while PPG and AXTA dropped a further 2.2% and 2.6%. Ecolab itself edged down 1.3% on Friday, and over the past week is roughly flat, down just 0.1%, against a median gain of 1.3% for its peer group. Its short interest at 1.7% of free float is one of the lowest readings in that cohort, and the trend is moving lower still.

Shorts have been exiting Ecolab at a notable pace. Short interest has fallen 11.7% over the past week and nearly 14.5% over the past month, bringing the float short to 4.7 million shares. The ORTEX short score has dropped from 35.4 to 32.5 over ten sessions, a steady move in the direction of reduced bearish conviction. Borrow availability is effectively unconstrained, with an availability reading that exceeds 9,999% of short interest, meaning there are roughly 192 million shares available to lend against fewer than 5 million already borrowed. Borrowing costs remain at 0.55%, well within normal territory. Options positioning offers no warning signal either: the put/call ratio at 0.38 is barely above its 20-day average of 0.37, with a z-score close to flat.

The analyst community is broadly constructive, with the consensus price target near $325 against a current price of $288.53, implying roughly 13% upside. UBS lifted its target to $344 earlier this month while maintaining a Buy rating. The forward earnings growth score ranks in the 97th percentile across the ORTEX universe. The bull case centres on Ecolab's 90%-plus recurring revenue, pricing power in a $152 billion addressable market, and management's guidance for 14 to 15% EPS growth in the second half of 2026, reinforced by the July 2026 CoolIT acquisition lifting the Global High-Tech segment toward $1.5 billion in annualised revenue. The bear case is more about execution than deterioration: volume growth was only 1% in the first quarter, Paper exposure remains a drag at over $1 billion in revenue and declining, and the stock's 32x trailing earnings leaves little room for disappointment relative to what the market already prices in.

Institutional ownership is dominated by long-term holders. Cascade Investment holds 10.4% of shares with no reported change, while BlackRock added 244,000 shares through to September 30. No activist holders are on the 13D register, and recent insider activity on the EDGAR record consists entirely of routine director compensation awards in late September, none of which represent open-market conviction buys. The 90-day net insider position is modestly negative at roughly $6.2 million in net sales.

Tuesday's print will test whether the company's pricing-driven margin expansion thesis is holding up in the face of weaker industrial end markets, and whether the CoolIT integration is tracking to the growth trajectory that justified the premium paid to reach the $1.5 billion annualised revenue figure.

Stocks in this article

See the live data behind this article on ORTEX.

Open ECL on ORTEX →

How this article was generated

Generated
24 Oct 2026, 04:05
Data as of
24 Oct 2026, 04:00
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.